Shizuoka, Japan

Koji Takano

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 10.4

ph-index = 2

Forward Citations = 30(Granted Patents)


Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):

Title: Koji Takano: Innovator in Peptide Compound Research

Introduction

Koji Takano is a prominent inventor based in Shizuoka, Japan. He has made significant contributions to the field of peptide compounds, holding a total of 7 patents. His work focuses on developing innovative methods for drug discovery, particularly for challenging targets.

Latest Patents

One of his latest patents is a peptide-compound cyclization method. This invention aims to provide methods for discovering drugs that are effective for tough targets, which have traditionally been difficult to identify. The invention relates to novel methods for cyclizing peptide compounds, as well as novel peptide compounds and libraries that comprise these compounds. Another notable patent is for a cyclic compound that has a selective KRAS inhibitory effect on HRAS and NRAS. This discovery includes cyclic compounds that selectively inhibit KRAS and interact with an amino acid residue specific to KRAS.

Career Highlights

Koji Takano is associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company. His work at the company has been instrumental in advancing research in peptide compounds and their applications in drug development.

Collaborations

Throughout his career, Takano has collaborated with notable colleagues, including Mikimasa Tanada and Atsushi Matsuo. These collaborations have further enriched his research and contributed to the success of his innovative projects.

Conclusion

Koji Takano's contributions to peptide compound research and drug discovery highlight his role as a key innovator in the field. His patents reflect a commitment to overcoming challenges in drug development, making a significant impact on the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…